Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
8.010 USD  +0.080 (+1.01%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Achillion Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Achillion Announces Updated Phase 2 Results Including Early Sustained Virologic Response on ACH-3102 Plus Ribavirin in Genotype 1b Treatment-Naive Hepatitis C Patients
April 23, 2013
from GlobeNewswire News Releases
(ACHN) Achillion Pharmaceuticals’ HCV Candidates Progress
April 21, 2013
Achillion Pharmaceuticals, Inc. (ACHN) recently commenced international phase II studies on... Visit StockBlogHub to view complete post. Read More
category White River Capital Inc , Transcept Pharmaceuticals Inc , Biotechnology , and 9 more.
from Stock Blog Hub
8 Biotechnology Stocks to Sell Now
April 17, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 6 more.
from InvestorPlace - Latest Headlines
Achillion (ACHN) Commences ACH-3102 Phase 2
April 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8254639 for the full story. Read More
from StreetInsider.com News Articles
Achillion Initiates Phase 2 Interferon-Free Trial of Sovaprevir and ACH-3102 for Genotype 1 HCV
April 16, 2013
All-Oral Trial to Evaluate the Safety and Efficacy of a 12-Week Regimen of Sovaprevir, ACH-3102 and Ribavirin for Genotype 1 Treatment-Naive HCV Patients Read More
from GlobeNewswire News Releases
Losers List: Achillion Pharmaceuticals, HMS Holdings Corp, Marvell Technology Group Ltd, CentraisEletricasBrasileiras SA
April 12, 2013
Lakeway, NY -- (SBWIRE) -- 04/12/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
7 Biotechnology Stocks to Sell Now
April 10, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
E*TRADE Financial Corporation (NASDAQ:ETFC), Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Added to Growing Stock Report's NASDAQ Decliners Watch List.
April 04, 2013
New York, NY -- (SBWIRE) -- 04/04/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding E*TRADE Financial Corporation (NASDAQ:ETFC), Astex Pharmaceuticals, Inc.... Read More
from SBWire - Latest Press Releases
7 Biotechnology Stocks to Sell Now
April 03, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
7 Biotechnology Stocks to Sell Now
March 27, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
7 Biotechnology Stocks to Sell Now
March 20, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Stocks Review: Achillion Pharmaceuticals, Acorda Therapeutics Inc, Active Power, Adept Technology Inc
March 18, 2013
Lakeway, TX -- (SBWIRE) -- 03/18/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Notable Healthcare Stocks: Baxter International Inc, Achillion Pharmaceuticals, Teva Pharmaceutical Industries Ltd, Astex Pharmaceuticals Bradley
March 18, 2013
Lakeway, TX -- (SBWIRE) -- 03/18/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
8 Biotechnology Stocks to Sell Now
March 13, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 6 more.
from InvestorPlace - Latest Headlines
Drug Approvals, Breakthrough Treatments and Royalties - Research Report on Celgene Corporation, Onyx Pharmaceuticals, Sarepta Therapeutics, VIVUS and Achillion Pharmaceuticals
March 08, 2013
from PR Newswire
Stocks to Watch: Gevo, Peregrine Pharmaceuticals, Vale SA, Achillion Pharmaceuticals
March 07, 2013
Dallas, TX -- (SBWIRE) -- 03/07/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012
March 07, 2013
Five Star Equities Provides Stock Research on Achillion Pharmaceuticals and ISIS Pharmaceuticals Read More
from Marketwired News Releases
7 Biotechnology Stocks to Sell Now
March 06, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Stocks to Watch: Orexigen Therapeutics, Workday Inc, Stratasys, Achillion Pharmaceuticals
March 05, 2013
Lakeway, TX -- (SBWIRE) -- 03/05/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Monday`s Top Stock Gainers: Barnes & Noble, Global Geophysical Services, Achillion Pharmaceuticals, Albany Molecular Research
March 04, 2013
Lakeway, TX -- (SBWIRE) -- 03/04/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
UPDATE: Piper Jaffray Cuts PT to $15 on Achillion Pharmaceuticals on Equity Offering Dilution
March 04, 2013
Piper Jaffray maintained Achillion Pharmaceuticals (NASDAQ: ACHN ) with an Overweight rating and lowered the price target from $16.00 to $15.00. Piper Jaffray said, "Achillion now holds proforma cash... Read More
category Benzinga , Piper Jaffray , ACHN , and 3 more.
from Latest Articles from Benzinga.com
Achillion to Present at Two Upcoming Investor Conferences
March 01, 2013
from GlobeNewswire News Releases
Achillion Pharmaceuticals Announces Closing of Public Offering
February 27, 2013
Underwriters Exercise Option to Purchase Additional Shares Read More
from GlobeNewswire News Releases
Stocks to Watch (Oneok Partners, Achillion Pharmaceuticals, First Solar, ONEOK)
February 27, 2013
Las Vegas, NV -- (SBWIRE) -- 02/27/2013 -- Cogonews.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news... Read More
from SBWire - Latest Press Releases
7 Biotechnology Stocks to Sell Now
February 27, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
February 26, 2013
from PR Newswire
Snag ACHN Even Lower Than Its Secondary?
February 25, 2013
Looking back to 4 days ago, Achillion Pharmaceuticals Inc. (ACHN) priced a 15,000,000.00 share secondary stock offering at $8.40 per share. Read More
category Stocks
from Market News Video
Stocks to Eyes On: Eastman Chemical Company, Gol Linhas Aereas Inteligentes SA, J.C. Penney Company, Inc., Achillion Pharmaceuticals, Inc.
February 25, 2013
Lakeway, TX -- (SBWIRE) -- 02/25/2013 -- vb-news.net, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following... Read More
from SBWire - Latest Press Releases
Stocks with Unusual Volumes: Sanofi, CombiMatrix Corporation, Achillion Pharmaceuticals, AVG Technologies
February 22, 2013
Lakeway, TX -- (SBWIRE) -- 02/22/2013 -- vb-news.net, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following... Read More
from SBWire - Latest Press Releases
Biotech Stocks: Sequenom, Amicus Therapeutics, Theravance Inc, Achillion Pharmaceuticals
February 22, 2013
Lakeway, TX -- (SBWIRE) -- 02/22/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here